UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Molecular cancer therapeutics, 2017-07, Vol.16 (7), p.1246-1256

2017

Volltextzugriff (PDF)

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation

Nature cell biology, 2011-02, Vol.13 (2), p.174-181

2011

Volltextzugriff (PDF)

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis

The Journal of clinical investigation, 2011-11, Vol.121 (11), p.4526-4536

2011

Volltextzugriff (PDF)

Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6109-6117

2008

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Potentiates MCM7-Mediated DNA Replication through Tyrosine Phosphorylation of Lyn Kinase in Human Cancers

Cancer cell, 2013-06, Vol.23 (6), p.796-810

2013

Volltextzugriff (PDF)

ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway

Science signaling, 2010-02, Vol.3 (108), p.ra9

2010

Volltextzugriff (PDF)

The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential

Cancer cell, 2015-08, Vol.28 (2), p.198-209

2015

Volltextzugriff (PDF)

Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma

Journal of immunotherapy (1997), 2005-03, Vol.28 (2), p.129-135

2005

Volltextzugriff (PDF)

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

Cancer gene therapy, 2004-11, Vol.11 (11), p.740-747

2004

Volltextzugriff (PDF)

KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ

Molecular cell, 2009-10, Vol.36 (1), p.131-140

2009

Volltextzugriff (PDF)

Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (8), p.2632-2640

2008

Volltextzugriff (PDF)

IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

Cell, 2007-08, Vol.130 (3), p.440-455

2007

Volltextzugriff (PDF)

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Nature cell biology, 2008-02, Vol.10 (2), p.138-148

2008

Volltextzugriff (PDF)

Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB

Cancer cell, 2013-10, Vol.24 (4), p.423-437

2013

Volltextzugriff (PDF)

The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription

Molecular carcinogenesis, 2009-11, Vol.48 (11), p.1048-1058

2009

Volltextzugriff (PDF)

IKKα Activation of NOTCH Links Tumorigenesis via FOXA2 Suppression

Molecular cell, 2012-01, Vol.45 (2), p.171-184

2012

Volltextzugriff (PDF)

Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer

Molecular cancer therapeutics, 2012-10, Vol.11 (10), p.2212-2221

2012

Volltextzugriff (PDF)

The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma

American journal of cancer research, 2016-01, Vol.6 (11), p.2489-2501

2016

Volltextzugriff (PDF)

TNFα induces HIF-1α expression through activation of IKKβ

Biochemical and biophysical research communications, 2009-11, Vol.389 (4), p.640-644

2009

Volltextzugriff (PDF)

Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models

Cancer cell, 2007-07, Vol.12 (1), p.52-65

2007

Volltextzugriff (PDF)

IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance

International journal of molecular medicine, 2008-11, Vol.22 (5), p.633-638

2008

Volltextzugriff (PDF)

Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein?

American journal of translational research, 2010-01, Vol.2 (1), p.56-64

2010

Volltextzugriff (PDF)

Phosphorylation of ARD1 by IKKβ contributes to its destabilization and degradation

Biochemical and biophysical research communications, 2009-11, Vol.389 (1), p.156-161

2009

Volltextzugriff (PDF)

Enhancement of Bik antitumor effect by Bik mutants

Cancer research (Chicago, Ill.), 2003-11, Vol.63 (22), p.7630-7633

2003

Volltextzugriff (PDF)

Abstract 2598: Synergistic effect of ibrutinib and inhibitors targeting TLR signaling in ABC subtype of diffuse large B-Cell lymphoma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2598-2598

2015

Volltextzugriff (PDF)

1 – 25 von 339

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(305)
Mit Volltextzugriff
(314)

Publikationsform

Sprache

Englisch
(337)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation

APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis

Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer

Epidermal Growth Factor Receptor Potentiates MCM7-Mediated DNA Replication through Tyrosine Phosphorylation of Lyn Kinase in Human Cancers

ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway

The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential

Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ

Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma

IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Epigenetic Roles of MLL Oncoproteins Are Dependent on NF-κB

The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription

IKKα Activation of NOTCH Links Tumorigenesis via FOXA2 Suppression

Targeting the IKKβ/mTOR/VEGF signaling pathway as a potential therapeutic strategy for obesity-related breast cancer

The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma

TNFα induces HIF-1α expression through activation of IKKβ

Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models

IKKβ suppression of TSC1 function links the mTOR pathway with insulin resistance

Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein?

Phosphorylation of ARD1 by IKKβ contributes to its destabilization and degradation

Enhancement of Bik antitumor effect by Bik mutants

Abstract 2598: Synergistic effect of ibrutinib and inhibitors targeting TLR signaling in ABC subtype of diffuse large B-Cell lymphoma

Suchergebnisse filtern